Methyprylon, or Noludar, is a sedative of the piperidinedione derivative family first developed by Hoffmann-La Roche. [2] This medicine was used for treating insomnia, but is now rarely used …

2005年6月13日 · Methyprylon, a piperidinedione CNS depressant, is close to barbituric acid in structure, but different enough to be called a "non-barbiturate" sedative-hynotic. Methyprylon is …

Methyprylon, a piperidinedione CNS depressant, is close to barbituric acid in structure, but different enough to be called a "non-barbiturate" sedative-hynotic. Methyprylon is used for …

THE purpose of this study was to evaluate the safety and efficacy of methyprylon (3,3-diethyl-2,4-dioxo-5-methylpiperidine),§ a Central-nervous-system depressant, which in laboratory animals …

Methyprylon is a sedative and hypnotic drug developed by Hoffmann-La Roche in the 1950s. It was marketed under the brand name Noludar as a treatment for insomnia.

Methyprylon, or Noludar, is a sedative of the piperidinedione derivative family first developed by Hoffmann-La Roche. [2] This medicine was used for treating insomnia, but is now rarely used …

Methyprylon is a sedative–hypnotic agent that has been used in the treatment of anxiety, nervousness, and sleep disorders (insomnia). The drug was withdrawn from the US market in …

2013年11月8日 · Methyprylon - Get up-to-date information on Methyprylon side effects, uses, dosage, overdose, pregnancy, alcohol and more. Learn more about Methyprylon.

Methyprylon is a sedative of the piperidinedione derivative family that was previously used for the treatment of insomnia. However, with the introduction of newer drugs with fewer side effects, …

DrugCentral is online drug information resource created and maintained by Division of Translational Informatics at University of New Mexico.